VP-14637: Clinical Trials

3 trials of VP-14637, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow VP-14637: new trials by email Literature Review of VP-14637 trials Research Report on VP-14637

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Subjects With Intermittent, or Mild-to-Moderate Persistent, Asthma
MDT-637, Placebo - Drug Safety
Phase 1CompletedMicroDose Therapeutx, Inc102012-03-012012-05-22
A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Healthy Volunteers
MDT-637 - Drug Safety
Phase 1CompletedMicroDose Therapeutx, Inc362011-12-012012-04-12
A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MDT-637 in Healthy Volunteers
MDT-637 - Drug Safety, Respiratory Syncytial Virus Infections
Phase 1CompletedMicroDose Therapeutx, Inc482011-09-012012-04-12

Conditions studied

Respiratory Syncytial Virus Infections (3)

Sponsors

MicroDose Therapeutx, Inc (3)

Countries

United States (3)

Top investigators

Purvee Shah, MD (1)